Ole Andreas Halvorsen, 10% Owner at Urovant Sciences Ltd. (UROV), bought 21,608 shares at $8.39 ($163K) on 2019-05-20, disclosed to the SEC on 2019-05-20.
Open-market purchase of $163k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.79 | 5,408 | $37K | 22.5% |
| 2 | $7.36 | 6,200 | $46K | 28.0% |
| 3 | $7.98 | 8,285 | $66K | 40.6% |
| 4 | $8.39 | 1,715 | $14K | 8.8% |
| Total | $7.54 avg | 21,608 | $163K | 100% |
| Filing → |
| ZNTL | SELL | 2020-12-03 | $25.3M | — | Filing → |
| ADPT | SELL | 2020-01-30 | $245.4M | — | Filing → |
| UROV | BUY | 2019-06-19 | $262K | — | Filing → |